Proton pump inhibitor therapy after eradication may increase the risk of gastric cancer.
作者信息
Tan Mimi Chang, Graham David Y
机构信息
Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, Texas, USA.
出版信息
BMJ Evid Based Med. 2018 Jun;23(3):111-112. doi: 10.1136/bmjebm-2018-110935. Epub 2018 Mar 29.
Abstract
摘要
相似文献
1
Proton pump inhibitor therapy after eradication may increase the risk of gastric cancer.根除幽门螺杆菌后使用质子泵抑制剂治疗可能会增加患胃癌的风险。
BMJ Evid Based Med. 2018 Jun;23(3):111-112. doi: 10.1136/bmjebm-2018-110935. Epub 2018 Mar 29.
2
Long-term proton pump inhibitor use after eradication may create a gastric environment for -nitrosamine formation and gastric cancer development.根除幽门螺杆菌后长期使用质子泵抑制剂可能会为亚硝胺的形成和胃癌的发展创造一个胃部环境。
Gut. 2019 Jun;68(6):1131. doi: 10.1136/gutjnl-2018-316592. Epub 2018 May 25.
3
eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.根除治疗失败可能混淆了近期一项大规模健康数据库研究的结果，该研究显示质子泵抑制剂会增加胃癌风险。
Gut. 2018 Nov;67(11):2071-2072. doi: 10.1136/gutjnl-2017-315698. Epub 2017 Dec 15.
4
Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.内镜黏膜下剥离术后即刻行幽门螺杆菌根除治疗的疗效和安全性。
J Gastroenterol Hepatol. 2018 Jul;33(7):1341-1346. doi: 10.1111/jgh.14073. Epub 2018 Mar 7.
5
Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for : a retrospective cohort analysis.长期使用质子泵抑制剂是治疗后患胃癌的一个风险因素：一项回顾性队列分析。
Gut. 2018 Oct;67(10):1908-1910. doi: 10.1136/gutjnl-2017-315710. Epub 2017 Dec 22.
6
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.胃切除术后残胃的幽门螺杆菌根除治疗
Gastric Cancer. 2003;6(2):100-7. doi: 10.1007/s10120-003-0234-7.
7
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.含质子泵抑制剂的三联疗法治疗幽门螺杆菌感染：7天与14天疗程对比——韩国两种疗程的根除率均不理想
Helicobacter. 2007 Feb;12(1):31-5. doi: 10.1111/j.1523-5378.2007.00468.x.
8
Management of Helicobacter pylori infection after gastric surgery.胃手术后幽门螺杆菌感染的管理。
World J Gastroenterol. 2014 May 14;20(18):5274-82. doi: 10.3748/wjg.v20.i18.5274.
9
Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.质子泵抑制剂的使用与幽门螺杆菌阳性患者胃肠化生的剂量依赖性关联。
United European Gastroenterol J. 2021 Apr;9(3):343-353. doi: 10.1177/2050640620951403. Epub 2021 Mar 18.
引用本文的文献
1
Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans.膳食因素与美国退伍军人胃肠化生风险
Dig Dis Sci. 2021 May;66(5):1600-1610. doi: 10.1007/s10620-020-06399-9. Epub 2020 Jun 13.
本文引用的文献
1
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study.长期质子泵抑制剂治疗后胃癌发展的风险：一项基于人群的研究。
Gut. 2018 Jan;67(1):28-35. doi: 10.1136/gutjnl-2017-314605. Epub 2017 Oct 31.
2
Helicobacter pylori as an oncogenic pathogen, revisited.再探幽门螺杆菌作为致癌病原体的情况。
Expert Rev Mol Med. 2017 Mar 21;19:e4. doi: 10.1017/erm.2017.4.
3
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.幽门螺杆菌最新进展：胃癌、可靠的治疗方法及潜在益处
Gastroenterology. 2015 Apr;148(4):719-31.e3. doi: 10.1053/j.gastro.2015.01.040. Epub 2015 Feb 2.
Zotero 插件